Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells

Journal of Infectious Diseases

Volumn 182, Issue 4, 2000, Pages 1214-1217

  Jordan, Ingo ^a   Briese, Thomas ^a   Fischer, Nicole ^a   Lau, Johnson Yiu Nam ^b   Lipkin, W Ian ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Valeant Pharmaceuticals International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENCEPHALITIS; HUMAN; HUMAN CELL; MOSQUITO; NERVE CELL; PRIORITY JOURNAL; SUMMER; UNITED STATES; VIRUS REPLICATION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

ANTIVIRAL AGENTS; CELLS, CULTURED; DISEASE OUTBREAKS; HUMAN; MICROBIAL SENSITIVITY TESTS; NEW YORK CITY; OLIGODENDROGLIA; RIBAVIRIN; VIRUS REPLICATION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 0033805382     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315847     Document Type: Article

References (18)

1. Arboviruses (Togaviridae and Flaviviridae)
2. West Nile fever a reemerging mosquito-borne viral disease in Europe
3. The West Nile virus outbreak of 1999 in New York: The Flushing Hospital experience
4. Genetic analysis of the West Nile New York encephalitis virus
5. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States
6. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
7. Detection of West Nile virus sequences in cerebrospinal fluid
8. Update West Nile virus isolated from mosquitoes - New York, 2000
9. Increase of virus yields and releases of Borna disease virus from persistently infected cells
10. Broad-spectrum antiviral activity of 2-β-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent
11. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug
12. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: A randomized double-blind study
13. Lassa fever: Effective therapy with ribavirin
14. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome
15. Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy
16. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase, and preserves Th1 cytokine production but inhibits Th2 cytokine response
17. Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection
18. Intravenous ribavirin for hanta virus pulmonary syndrome: Safety and tolerance during 1 year of open-label experience